# Non-Inferiority Study Comparing the Subunit Vaccines Influvac and Agrippal in China

> **NCT00325260** · PHASE3 · COMPLETED · sponsor: **Solvay Pharmaceuticals** · enrollment: 900 (—)

## Conditions studied

- Healthy

## Interventions

- **BIOLOGICAL:** Influvac; subunit influenza vaccine

## Key facts

- **NCT ID:** NCT00325260
- **Lead sponsor:** Solvay Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 900 (—)
- **Last updated:** 2006-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00325260

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00325260, "Non-Inferiority Study Comparing the Subunit Vaccines Influvac and Agrippal in China". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00325260. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*